Clinical study on optimal dose of esketamine in pediatrc comfort medical treatment

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040406

Enrollment

Unknown

Registered

2020-11-28

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medium depth sedation and clinical anesthesia

Interventions

Three groups:Different doses of dextran

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatient minor surgery anesthesian for chidren aged 0-12 years,Medium depth sedation without cooperating examination or treatment,Anesthesia for all systems of surgery in children.

Exclusion criteria

Exclusion criteria: Neonates,premature infants and children with dysplasia,Children with special requirements for anesthesia

Design outcomes

Primary

Measure	Time frame
Clinical out comes;	—

Contacts

Public ContactHe Dingxiu

Longyan Second Hospital of Fujian Province

river2008@sina.com+86 13859551890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026